case studies

Real People. Real Biology. Real Change.

01

TITLE:

Revealing mechanisms, biomarkers, and early toxicity to help Amply prioritise their pipeline with real biological evidence.

DATE:

Feb 2, 2025

CLIENT:

AMPLY DISCOVERY

01

TITLE:

Revealing mechanisms, biomarkers, and early toxicity to help Amply prioritise their pipeline with real biological evidence.

DATE:

Feb 2, 2025

CLIENT:

AMPLY DISCOVERY

01

TITLE:

Revealing mechanisms, biomarkers, and early toxicity to help Amply prioritise their pipeline with real biological evidence.

DATE:

Feb 2, 2025

CLIENT:

AMPLY DISCOVERY

02

TITLE:

Delivering mechanism-level insight into IO enhancers to help Eidolon quickly select and optimise their next-generation agents.

DATE:

Nov 27, 2025

CLIENT:

EIDOLON THERAPEUTICS

02

TITLE:

Delivering mechanism-level insight into IO enhancers to help Eidolon quickly select and optimise their next-generation agents.

DATE:

Nov 27, 2025

CLIENT:

EIDOLON THERAPEUTICS

02

TITLE:

Delivering mechanism-level insight into IO enhancers to help Eidolon quickly select and optimise their next-generation agents.

DATE:

Nov 27, 2025

CLIENT:

EIDOLON THERAPEUTICS